Eli Lilly supports Alto Neuroscience in $45m Series C round

cafead

Administrator
Staff member
  • cafead   Nov 22, 2023 at 11:32: AM
via The funding will go towards the development of Alto Neuroscience's four CNS candidates, with Phase II study data readouts expected by early 2025.

article source